Results 11 to 20 of about 136,558 (265)
Cluster features in fibrosing interstitial lung disease and associations with prognosis
BMC Pulmonary Medicine, 2023 Background Clustering is helpful in identifying subtypes in complex fibrosing interstitial lung disease (F-ILD) and associating them with prognosis at an early stage of the disease to improve treatment management.
Yuanying Wang +5 more
doaj +1 more source
BMC Pulmonary Medicine, 2023 Background Pulmonary fibrosis (PF) is caused by a heterogeneous group of diseases, with a high inter-individual variability in disease trajectory. Identifying disease progression in patients with PF has impact on clinical management decisions.
Gizal Nakshbandi +9 more
doaj +1 more source
Cells, 2021 Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance.
Els Beijer +5 more
doaj +1 more source
Interstitial lung disease [PDF]
European Respiratory Review, 2013 This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
openaire +4 more sources
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review
European Respiratory Review, 2021 Over the past three decades, an increasing number of publications have reported the association between interstitial lung disease (ILD) and anti-neutrophil cytoplasmic antibody (ANCA) or ANCA-associated vasculitis (AAV). With this increased awareness, we
Suha Kadura, Ganesh Raghu
doaj +1 more source
EJNMMI Research, 2019 Background 18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the
Milou C. Schimmelpennink +3 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Background: Limited data are available regarding the entire spectrum of interstitial lung disease with a progressive fibrosing feature. We investigated the prevalence and prognostic predictive characteristics in patients with PF-ILD.Methods: This ...
Yuanying Wang +8 more
doaj +1 more source
Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
Respiratory Research, 2022 Background Hypersensitivity pneumonitis (HP) is a type of interstitial lung disease (ILD) with a variable disease course and prognosis ranging from inflammatory and self-limiting to irreversible and progressive pulmonary fibrosis.
Thomas Skovhus Prior +4 more
doaj +1 more source
Frontiers in Medicine, 2018 The enzyme telomerase reverse transcriptase (TERT) is essential for telomere maintenance. In replicating cells, maintenance of telomere length is important for the preservation of vital genetic information and prevention of genomic instability.
Reinier Snetselaar +5 more
doaj +1 more source
ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis
Cells, 2022 Sarcoidosis is an immune mediated granulomatous disease commonly affecting the lungs. Genome wide association studies identified many genomic regions that are shared among multiple immune mediated diseases.
Bekir Karakaya +5 more
doaj +1 more source